Purchase Order VA24917P0104
- Not listed
- This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
- This federal contract award is for "TRANSPLANT LABORATORY TESTING" services provided by Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services to support organ transplant programs. The contract, valued at $205,530.69, was awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract valued at...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization that specializes in providing advanced medical testing products and services to support organ transplant programs. The contract, valued at $127,833.75, is for laboratory services related to Caredx's AlloSure kidney and heart tests, AlloMap heart tests, and other genetic blood testing services for transplant patients. The contract is a definitive contract with a firm fixed...
- The Department of Veterans Affairs (VA) awarded a $120,000 firm fixed price purchase order to Caredx, Inc., doing business as Caredx, a for-profit organization, for XYNQAPI renal transplant software. The contract is for a 12-month base period and 12-month option period. This purchase order is part of a broader set of VA contracts with Caredx, which has received over $9 million in federal contracts from the VA to provide specialized medical testing products and services related to organ...
- The federal contract award is for laboratory services provided by Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract, valued at $241,463.75, was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx for the delivery of advanced genetic and molecular testing solutions focused on organ transplant diagnostics. The contract, which has a completion date of January 14, 2026, is a Firm Fixed Price Delivery Order, with no set-aside...
- This federal contract award is for the provision of TRANSPLANT TESTING KITS by Caredx, Inc., a for-profit organization that specializes in advanced medical testing products and services to support organ transplant programs. The contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), has a ceiling value of $2,397,593.00 and is structured as a Delivery Order on a Firm Fixed Price basis. The contract does not have a set-aside...
- The Department of Veterans Affairs (VA) has awarded a $18,466.34 firm-fixed-price delivery order contract to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide AlloMap molecular testing services for heart transplant patient monitoring. This delivery order is placed against a single-award indefinite delivery contract (IDC) valued at $787,000 that Caredx Lab Solutions holds with the VA's Veterans Integrated Service Network 17 (VISN 17), which runs through June 2027. The contract...
- This is a $193,171.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract is for laboratory reference testing services, specifically Caredx's specialized diagnostic solutions for organ transplant patients, including its AlloMap and AlloSure genetic and molecular testing products. The contract has an ultimate completion date of January 14,...
- This is a definitive contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $244,800.00, is for laboratory tests and specialty transplant services. The contract is not set aside and was awarded under the VA's Veterans Integrated Service Network 9 (VISN 9) to Caredx, which has been awarded multiple indefinite...
- This is a federal contract award to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $4,807,230.45, is for laboratory tests for post-transplant organ rejection and was awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of March 31, 2026....
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Caredx, Inc., a for-profit company that provides kidney care solutions. The $139,400.00 firm fixed price purchase order is for Caredx to supply specialized medical testing products and services related to organ transplant patients, including AlloMap gene testing, AlloSure kidney testing, and XYNQAPI renal transplant software. This contract is not associated with any set-aside designation. Caredx has received over $9 million in federal contract awards from the VA to support its healthcare programs across multiple Veterans Integrated Service Networks, helping to monitor transplant rejection through noninvasive testing. Caredx also holds two indefinite delivery contracts from the VA for genetic testing services, including a $1.4 million small business set-aside contract and a $1.96 million contract utilized by two VA networks to order over $785,000 in AlloMap and AlloSure testing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $139.4k | 4/19/17 |